• Revenues were down by 7% to $8.7bn for Q1 23 compared to Q1 22
• UBS booked a litigation provision of $665m in Q1 23 for a 15 years old US RMBS matter
• Net profit attributable to shareholders decreased by 52% to $1.03bn in Q1 23
• RoCET 1 was 9.1% for Q1 23 and below the 15-18% target range
• Net new money (NNM) inflow was $42bn for Q1 23 compared to $34bn for Q1 22
25 Apr 2023
Disappointing UBS Q1 23 figures due to an unexpected litigation provision
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Disappointing UBS Q1 23 figures due to an unexpected litigation provision
• Revenues were down by 7% to $8.7bn for Q1 23 compared to Q1 22
• UBS booked a litigation provision of $665m in Q1 23 for a 15 years old US RMBS matter
• Net profit attributable to shareholders decreased by 52% to $1.03bn in Q1 23
• RoCET 1 was 9.1% for Q1 23 and below the 15-18% target range
• Net new money (NNM) inflow was $42bn for Q1 23 compared to $34bn for Q1 22